Foresite Capital

Summary

In 2011 was created Foresite Capital, which is appeared as VC. The main department of described VC is located in the San Francisco. The company was established in North America in United States.

The current fund was established by Jim Tananbaum. The overall number of key employees were 11.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Foresite Capital, startups are often financed by Venrock, Third Rock Ventures, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are Cormorant Asset Management, ARCH Venture Partners, Paladin Capital Group. In the next rounds fund is usually obtained by Paladin Capital Group, Merieux Developpement, EcoR1 Capital.

The higher amount of exits for fund were in 2015. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 7-12 investment rounds annually. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from Foresite Capital is more than 1 billion dollars. Opposing the other organizations, this Foresite Capital works on 12 percentage points more the average amount of lead investments.

Among the various public portfolio startups of the fund, we may underline AveXis, Intarcia Therapeutics, Audentes Therapeutics Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Health Care, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.